(Q40963925)

25 September 2017

1 reference

title

Innovative treatment approaches for rheumatoid arthritis. Combination therapy (English)

1 reference

25 September 2017

Borigini MJ

1

1 reference

PubMed ID

8591649

25 September 2017

Paulus HE

series ordinal

2

1 reference

25 September 2017

1 November 1995

1 reference

Bailliere's clinical rheumatology

25 September 2017

1 reference

25 September 2017

9

1 reference

25 September 2017

4

1 reference

25 September 2017

689-710

1 reference

Suppression of collagen-induced arthritis by combination cyclosporin A and methotrexate therapy

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Radiographic changes in early rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Reversal of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Combination therapy in rheumatoid arthritis--study design

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

A toxicity index for comparison of side effects among different drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Optimizing combination chemotherapy for rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Adult and juvenile rheumatoid arthritis: current epidemiologic concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Systemic treatment of severe psoriasis--the role of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Antimalarial agents compared with or in combination with other disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Combined therapy of rheumatoid arthritis with gold and chloroquine. I. Evaluation of the therapeutic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

Inverting the therapeutic pyramid: observations and recommendations on new directions in rheumatoid arthritis therapy based on the author's experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980309-7

7 January 2021

10.1016/S0950-3579(05)80309-7

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8591649